RealDiagnostics

Unraveling the Science Behind Effective Antibiotic Treatment

A ntimicrobial resistance poses a significant global health threat, rendering once-effective antibiotics less potent against bacterial infections. Antimicrobial susceptibility testing (AST) is a critical laboratory technique that guides healthcare providers in choosing appropriate antibiotics for individual patients. This article examines the principles, methods, and clinical significance of AST, shedding light on its role in combating antibiotic resistance and improving patient outcomes. Antimicrobial Susceptibility Testing AST is a cornerstone of effective antibiotic therapy. As bacteria evolve and develop resistance mechanisms, it becomes essential to identify the most suitable antibiotics for treating specific infections. Traditional empiric antibiotic therapy, based on broad-spectrum antibiotics, is increasingly becoming less effective due to the emergence of resistant strains. AST provides valuable data that help healthcare providers pre scribe targeted antibiotic therapy, minimizing the use of broad-spectrum antibiotics and mitigating the risk of antibiotic resistance. Principles of Antimicrobial Susceptibility Testing AST assesses the sensitivity of bacterial isolates to different antibiotics by measuring their ability to inhibit bacterial growth. The main prin ciples include: Culture of Bacterial Isolates: Laboratories isolate bacteria from patient samples, such as blood, urine, or respiratory secretions, on culture media. Once grown, bacterial colonies are subjected to AST. Determination of Minimum Inhibitory Concentration (MIC): AST determines the MIC, which is the lowest concentration of an antibiotic that inhibits visible bacterial growth. A range of antibiotic concentrations is tested against the bacterial isolate, and the MIC is re corded. Interpretation of Results: The MIC values are compared to standardized breakpoints established by clinical guidelines. The breakpoints categorize isolates as susceptible, intermediate, or resistant to the antibiotic, guiding healthcare providers in treatment decisions.

14 | Real Diagnostics Magazine